Tom Ransohoff

Principal at RTI Consulting, LLC

Speaker

Tom Ransohoff has broad experience in the development and manufacture of biologic drugs and in the management of technology-based start-up firms. He is currently Principal, RTI Consulting, LLC, providing strategic and technical consulting services to biotech firms; President, DuAble, Inc., an antibody conjugation technology and services provider; and an Operating Partner with Keensight Capital. Previously, Mr. Ransohoff was Technical Head, Biologics Franchise for National Resilience, joining through Resilience’s acquisition of 4th Dimension Bioprocess (4D), where he was a co-founder and COO. He holds a Bachelor's from MIT and a Master's from UC Berkeley, both in Chemical Engineering.